Friday, March 17, 2006
There's been plenty of coverage of the British clinical trial of a drug directed at treating leukemia, MS, and arthritis that went very, very wrong, with two participants suffering very serious side effects. The best summary coverage I've seen is, not surprisingly, the BBC's, but I also keep an eye on The Consumerist's. TeGenero is posting statements as well. (Update: So is Parexel, the US-based contract research company that was running the study.)
I have not seen a copy of the consent form, but it'd be interesting to see.